Forex Easy
Forex Easy |
- Best Forex Trading Platform OctaFX for BIG PROFITS. Deposit/Withdraw in INR Start Forex Trading Now
- Experience Matters
- Simple 15 min Forex Scalping Strategy
- 7 Penny Stocks With Further to Fall
- Cara Mencairkan Uang Forex FBS ke BCA/ Mandiri/ BNI/ BRI
- Success Factors
- One Day Swing Trades – Set and Forget Forex System
- Forecast for USD/JPY on December 17, 2020
- Another 10X Winner | InvestorPlace
- Ermənilər niyə İrandakı hadisələrdən çox narahatdır ?-ətraflı xəbərdə-forex bonus
| Best Forex Trading Platform OctaFX for BIG PROFITS. Deposit/Withdraw in INR Start Forex Trading Now Posted: 17 Dec 2020 03:59 AM PST
 |
| Posted: 17 Dec 2020 03:03 AM PST I recently attended a PMI event on the age old question of what makes a project more successful than another. The discussion started by stating the obvious need to focus on the 5 W’s, but also the importance of ‘how’ things are done. The discussion was primarily philosophical, asking us to each think of the differentiators. There isn’t a one size fits all approach to success, and while checklists and “best practices” are helpful, I believe it’s the team’s application and foresight that goes into the application of a tool or method that determines success. Sure, guidance from other sources is helpful, but the ability to apply experience and intellect is what makes it all come together. They say you need 10,000 hours experience in an area to become an “expert” and the more experience and diversity in your background, the more scenarios you have encountered. Armed with our own experiences, we must be magnets for knowledge from others. Knowing how to learn, identifying areas needing growth and knowledge in ourselves and knowing where to go for the answers is very important. I think formal education helps in this area and helps build resourcefulness. It is impossible to always know all the answers. The ability to find the answers and make timely decisions based on the information available is what really matters. Awareness of a better way and for continuous improvement in all we do is what sets apart those with stellar results compared with those with mediocre and just satisfactory results. Below are some tips I recommend for setting yourself, and your projects apart from your peers:
Knowledge work requires us to always be anticipating events, bettering ourselves through continuous learning and applying our lessons learned to all we do. The more projects we have under our belt, the more situations we have seen. This exposure allows us to identify and anticipate events those with less experience may not have yet encountered.  |
| Simple 15 min Forex Scalping Strategy Posted: 17 Dec 2020 02:42 AM PST
 |
| 7 Penny Stocks With Further to Fall Posted: 17 Dec 2020 02:21 AM PST November was an absolutely wild month for the stock market. Any number of companies that had been total dogs all year suddenly took off. Everywhere you looked, things were going up 25%, 50% or more — virtually overnight. Airlines, restaurants, retail, the novel coronavirus losers roared back to life. In this environment, traders have started picking through penny stocks looking for the next big comeback story. However, not all the trash is going to turn into treasure. Many penny stocks are priced low precisely because their forward prospects are dour. In a market this boisterous, there's a huge opportunity cost to investing in penny stocks that are unlikely to ever recover. So, if you're holding any of these seven penny stocks — or pondering a new position — I'm here to tell you to sell or avoid them:
Northern Dynasty Minerals (NAK)
 Source: Shutterstock
Northern Dynasty Minerals is a junior gold exploration company focused almost exclusively on the Pebble Project in Alaska. Pebble is not a working mine yet, or anything close to it. Rather, it's a huge gold deposit that is still awaiting permitting from the government to continue development. Unfortunately for Northern Dynasty, the project is located in a remote and pristine corner of Alaska near a vital salmon fishery. Northern Dynasty has tried to advance the project for 13 years, however it has faced persistent roadblocks. First, the Obama Administration kept it from happening. Then, it appeared the Trump Administration might let Pebble go ahead. However, that fell through. Given concerns about the mine's impact on nearby salmon — potentially damaging Alaska's billion-dollar fishing industry — the U.S. Army Corps of Engineers denied the company's permit last month. Northern Dynasty can appeal the ruling of course. But if they couldn't convince the pro-business Trump team to give the mine the go-ahead, it almost certainly won't happen under Biden. What value does a company have whose mine is unlikely to be built for at least the next four years, and quite possibly far longer than that? For more context, consider that the company had $48 million of cash as of last quarter and it loses about $50 million per year in operating costs. So you've got a non-functional mine site and less than a year's worth of cash. As of now, speculators are still supporting a $160 million market capitalization for this. That's crazy. Don't let the low share price fool you: There's a ton of outstanding shares of NAK stock and thus this thing should continue to plunge in coming months as shareholders wake up to the reality that the mine simply isn't happening anytime soon. Alkaline Water (WTER) Source: Shutterstock If you follow certain celebrities, you've probably heard about the Alkaline Water trend. Some nutrition folks are suggesting that it's smart to consume beverages with a high pH level as this naturally balances out the heavy acidity within the human body. In theory, this is supposed to improve people's health and well-being. In practice, according to the Mayo Clinic, alkaline water is likely no better than drinking normal neutral pH water. While the science doesn't necessarily support the movement, high pH drinks have gained some consumer appeal nonetheless. And WTER stock is a direct play on the trend, as it has been building distribution for its less acidic water for years. As that business hasn't really taken off, it has started doing more additions to its product line-up, including flavored beverages and CBD-infused products. All in all, Alkaline Water has managed impressive top-line revenue growth. Since 2017, revenues have bubbled up from $13 million to $41 million per year. However, the operating loss has surged from $3 million to $14 million per year over the same span. So far, the company hasn't found a way to grow profitably. Given the seemingly gimmicky nature of its core business, it's hard to say whether a mass market will ever develop for Alkaline Water's products. In the meantime, folks are fueling a $78 million market capitalization for WTER stock even though it generates just $40 million in annual sales and loses sizable sums of money in doing so. Look for shares to continue sliding in coming quarters as dilution adds up. As of last quarter, the company had just $4 million in cash. So, given the size of its losses, it will likely raise more funds soon. Chesapeake Energy (CHKAQ) Source: IgorGolovniov / Shutterstock.com I recently explained why investors are running out of time to sell their Chesapeake Energy stock. Chesapeake is well into its bankruptcy reorganization process. At the end of it, CHKAQ stock will be cancelled, rendering shares worthless. Some people seem to be confused, though. CHKAQ stock spiked as much as 20% in recent days, for example, as part of a broader rally in the energy sector. However, this is not a sound trading strategy. Regardless of how much the oil and gas markets may recover, none of that profit will accrue to anyone who owns Chesapeake Energy's old stock. All the economic value of the company will now go to the various classes of bondholders. Chesapeake may have a storied name in the oil and gas space, but as a trading stock, there is no value here whatsoever. Washington Prime Group (WPG) Source: Shutterstock Will traditional shopping malls be able to make a post-Covid recovery? It remains an open question. Large mall operators face significant challenges and have seen their share prices battered over the past year. But you can make a case that the giants like Simon Property Group (NYSE:SPG) will do better in 2021 once social distancing measures can be relaxed. Washington Prime Group? Not likely. Unfortunately, the B-tier regional mall operator won't have that chance because it operates predominately smaller regional malls that simply don't have the same draw in the internet age. And Washington Prime doesn't have the balance sheet capacity or time required to redevelop its properties into something more fitting with the new economic climate. Already, Washington Prime's comparable smaller mall peers are reorganizing. Pyramid, CBL & Associates, and Pennsylvania Real Estate Investment Trust (NYSE:PEI) have all filed bankruptcy this year. Yet folks still haven't thrown in the towel on WPG stock. In fact, WPG stock has doubled in recent weeks, reclaiming the $1 mark for the time being. However, Washington Prime will soon follow its peers, given its terrible balance sheet. Fitch recently downgraded Washington Prime debt to the lowly "CC" rating as the ratings agency sees it as "probable" that the company's debt will be restructured or default within the next 12 months. Fitch also highlighted the Washington Prime's poor competitive position:
In any case, if the creditors will have to make sacrifices, common shareholders are likely to get next to nothing. Thus, the recent rally in WPG stock is baseless. If you want to play a recovery, stick to the healthier mall plays like Simon. iBio (IBIO) Source: Shutterstock I've sounded the alarm on shares of overvalued IBIO stock all year. With the Covid-19 vaccines now approaching the finish line, the clock has wound down on firms like iBio that were longshots in the race to develop their own products for the virus. And without Covid-19 excitement, what's left for iBio? Not a lot. Not much at all, in fact. Over the past decade, iBio has never generated more than $2 million of revenue in a single year. Read back through its press releases, and iBio has launched a ton of initiatives to address a textbook's selection of medical issues. Yet, time after time, nothing comes from it. Covid-19 looks to be another such case; iBio generated a ton of coronavirus publicity but couldn't turn it into tangible earnings. Despite this track record, shareholders are still giving iBio a generous valuation today. To put iBio's valuation in stark relief, consider the following. On Dec. 7, IBIO stock was trading around $1.50 per share. The next day, it announced it was issuing $35 million of IBIO stock at less than $1.20 per share to raise funds. Even today, iBio still has a market cap of $233 million. Yet, in raising a paltry $35 million, that action tanked the stock price by 20%. This speaks to the fundamental lack of demand for IBIO stock from institutional investors. Thus, as traders get bored of the Covid stocks and sell, look for shares to keep deflating. IBIO stock sold for 30 cents before the pandemic took off. It may return there again in coming months. Hall of Fame Resort & Entertainment (HOVF) Source: Rosamar / Shutterstock.com Next up, we have Hall of Fame Resort & Entertainment. For those unfamiliar, this is a company put together to try to monetize the National Football League's (NFL) Hall of Fame in Canton, Ohio. At the time of going public via a special purpose acquisition company (SPAC), the company had minuscule revenues, even before taking Covid-19 into account. However, the big idea here was to try to turn the Hall of Fame into a wide-reaching tourist draw by building a massive indoor water park, shopping center and hotel complex. According to the HOFV stock presentation, this was supposed to work because Ohio is centrally located and near to the majority of NFL franchises. While this may have sounded great on paper, in reality, the demand for a massive water park and shopping center in a small Ohio city was probably not great, even prior to Covid. It's certainly tenuous now. Even the new American Dream megamall in the New York City metro area is struggling due to the pandemic and changing consumer preferences. If that project could fail in the country's biggest city, there's reason to skeptical of this rollout in Canton. What's worse, Hall of Fame came public last month with a significant chunk of debt. This complicates the challenge of trying to raise capital to fund a questionable expansion plan all during a health crisis. Needless to say, this SPAC has been a massive failure, plunging from $10 to $1.39 already. Even so, as the company has scant revenues and is losing money, shares could have much further to decline. There are better bets out there; just ask Baltimore Ravens fans. Ideanomics (IDEX) Source: nrqemi / Shutterstock.com Electric vehicle (EV) stocks have been huge in 2020. Some of them will invariably continue to be big winners in 2021. Others, like Ideanomics, will not. And it seems that we're starting to see some sorting out of the field. Particularly with the gold rush mentality now, as every EV company out there prepares its own SPAC offering, the market is getting flooded with options. Thus, the lower-quality companies like Ideanomics are struggling to retain investor interest. IDEX stock spiked from $1 to $4 earlier this year as it pivoted its business model to electric vehicles. As there were still few EV stocks at that time, this one stood out. Now though, the company's issues have surfaced. For one, the company has previously chased hot fads such as blockchain and on-demand video streaming. Once those faded, it invariably switched to some new thing. Thus, the commitment to EVs may fade if Ideanomics decides to pivot again to something newer and more exciting. There are related questions about how serious Ideanomics is with its EV business. Short-seller Hindenburg Research blasted the company, saying that Ideanomics had doctored photos of a purported sales location in China and that there was little evidence of the company actually doing business in EVs. While the company denied the report, it clearly had an impact; shares have been sinking for awhile now. In any case, there are plenty of higher-quality EV stories to look at; few people are likely to remember IDEX stock by this time next year. On the date of publication, Ian Bezek did not have (either directly or indirectly) any positions in the securities mentioned in this article. Ian Bezek has written more than 1,000 articles for InvestorPlace.com and Seeking Alpha. He also worked as a Junior Analyst for Kerrisdale Capital, a $300 million New York City-based hedge fund. You can reach him on Twitter at @irbezek.  |
| Cara Mencairkan Uang Forex FBS ke BCA/ Mandiri/ BNI/ BRI Posted: 16 Dec 2020 10:58 PM PST
 |
| Posted: 16 Dec 2020 09:49 PM PST  |
| One Day Swing Trades – Set and Forget Forex System Posted: 16 Dec 2020 09:42 PM PST
 |
| Forecast for USD/JPY on December 17, 2020 Posted: 16 Dec 2020 09:19 PM PST USD/JPY The yen continues its planned movement to the nearest target level of 103.18 – to the minimum of November 6. Pinning below it opens the second target 102.35.
On the four-hour chart, yesterday’s surge in the price at the announcement of the results of the Fed meeting reached exactly the MACD line, from which, as from the current resistance, it quickly changed to a fall. As the decline continues, we are awaiting the price at the second target level of 102.35 with a probability of 70%.
The material has been provided by InstaForex Company – www.instaforex.com  |
| Another 10X Winner | InvestorPlace Posted: 16 Dec 2020 09:14 PM PST Investing in legal gray areas … the next controversial market sector offering big returns … the company in Luke Lango's crosshairs
Nearly two years ago, we featured investment research from Matt McCall about the legalized marijuana sector. The feedback from readers ran the spectrum from supportive, to unsure-yet-open-minded, to outraged. In response, I wrote a Digest explaining our position. In a nutshell, whatever your stance on legalized marijuana, we respect it, and aren't here to change it. We don't feel it's our place to judge the morality of marijuana, or anything else, for that matter. Doing so would inevitably mean we'd censor or promote content based on our own notion of right and wrong. But who are we to make such decisions for you? Instead, we believe our responsibility is to provide the most current, well-researched, thoughtful investment insights in the market. The decision to act upon that research, or not act, is wholly up to you. In response to that Digest, we received even more mixed feedback.
I found this email interesting for two reasons … First, it gave ultimate authority to the federal government rather than individual state governments. But on what grounds are federal laws more moral, just, or wise than state laws? After all, our nation's system of Federalism supports a balance of power between state and federal governments, not a blanket deferral to federal laws. Second, the federal government's position on significant social issues has changed over the years. For example, take alcohol. From 1920 to 1933, the United States government banned the production, importation, and sale of alcohol. As we know, alcohol is now legal. Was alcohol any different when it was illegal versus legal? If not, then doesn't that call into question the federal government's own judgement since it reversed its position? Or we could point to birth control. The Comstock Act was a federal law that, practically speaking, made birth control illegal. A husband and wife violating this law in the privacy of their own home could be arrested and subjected to a one-year prison sentence. The law wasn't fully repealed until 1965. I believe most people would agree that birth control has been, at large, a positive for society. So, should we have ignored such personal judgments and rallied against birth control purely because the federal government prohibited it? Fast-forward to today, and the federal government's position is changing again. As we noted in Monday's Digest, the House of Representatives just passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which would remove marijuana from the Controlled Substances Act. Though not yet a law, the movement suggests federal marijuana legality is likely a matter of "when" not "if." So, personal moral views on marijuana aside, if we assume that the reader above didn't consider a marijuana investment based purely on federal illegality, then there's a sad, missed opportunity cost … This person missed huge returns (before the sector crashed) due to a law that is now in the process of being reversed. That's genuinely unfortunate.
Because we're about to go through this exact same process all over again. Today, certain cities have already legalized another taboo substance. And earlier this fall, the first state in the nation officially legalized it. Other states are exploring legalization. Despite all this, it's still a Schedule 1 drug according to federal law. Meanwhile, similar to the early days of the marijuana sector, there will be massive investment gains. In fact, they're already happening … Luke Lango and his Daily 10X Stock Report subscribers just toasted their second 1,000%+ returning stock, pushed higher by the topic we'll discuss today. And this 10Xer needed less than six months to happen. So, in this Digest, let's dive into another controversial investment sector with massive wealth-generating potential. We present it without moral judgement — rather, with the belief that you are fully capable of deciding what is right and wrong for yourself. With that in mind, let's talk about psychedelics.
For newer Digest readers, the Daily 10X Stock Report was created earlier this year for one sole purpose:
Luke's subscribers recently celebrated their first-such 10X winner — Chinese electric vehicle company, NIO. As I write, 10X subscribers who acted on Luke's recommendation back on May 27th have watched NIO climb more than 1,300% before its recent pullback (it's still up 1,052% as I write). Fresh on the heels of the NIO-celebration, Luke has done it again with the pick we'll discuss today. But before we get into company, let's discuss the trend powering the gains. Here's Luke:
In his issue, Luke details more of the psychedelic industry's transition toward the mainstream. He then suggests that today, it's where the marijuana sector was back in 2015. Back to Luke on what this means for investors:
***So, which psychedelic stock is behind Luke's second 10X-winner?
MindMed (MMEDF). Luke explains that it's a tiny, $60 million company that is pioneering a new class of psychedelic-inspired medicines for the treatment of various mental and behavioral health issues. The company's portfolio of psychedelic medicine is aimed at two huge markets: addiction and ADHD. Here's Luke with more:
In terms of sizing the market for MindMed, Luke points toward worldwide pharma sales for opioid abuse totaling $2.9 billion in 2019. Meanwhile, worldwide pharma sales for ADHD totaled $9.2 billion in 2019. That's a combined $12 billion market that MindMed is seeking to disrupt.
***So far, here's what that's meant for MMEDF's stock since Luke highlighted it to readers
Now, before you think that you're too late, Luke wrote to subscribers that this stock will see 5,000%+ upside going forward.
As we wrap up, another big "congratulations" to 10X subscribers on their second 1,000%+ winner since May. We expect there will be plenty more to come. In the meantime, we'll keep you updated on the federal government's stance toward marijuana and psychedelics here in the Digest. With history as our guide, we expect changes are on the way. Have a good evening, Jeff Remsburg  |
| Ermənilər niyə İrandakı hadisələrdən çox narahatdır ?-ətraflı xəbərdə-forex bonus Posted: 16 Dec 2020 05:51 PM PST |
| You are subscribed to email updates from Forex Easy. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States | |
Comments